{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T10:10:39Z","timestamp":1687515039325},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00101-012-2041-1","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T08:00:06Z","timestamp":1339574406000},"page":"483-496","source":"Crossref","is-referenced-by-count":5,"title":["Thrombozytenfunktion \u2013 neue Medikamente, neue Assays","Platelet function: new drugs, new assays"],"prefix":"10.1007","volume":"61","author":[{"given":"E.","family":"Mahla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"H\u00f6chtl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pr\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K.","family":"Freynhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"2041_CR1","unstructured":"Regionalan\u00e4sthesie unter Gerinnungshemmender Medikation \u2013 Empfehlungen der Arbeitsgruppe \u201ePerioperative Gerinnung\u201c der \u00d6sterreichischen Gesellschaft f\u00fcr Anaesthesiologie, Reanimation und Intensivmedizin. http:\/\/wwwoegariat\/web_files\/dateiarchiv\/116\/Empfehlung%20Regionalan%C3%A4sthesie%20unter%20Gerinnungshemmung%202011pdf. 2011."},{"key":"2041_CR2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1538-7836.2006.02088.x","volume":"4","author":"Altman","year":"2006","unstructured":"Altman R, Scazziota A, DE Lourdes Herrera M et al (2006) Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost 4:2022\u20132027","journal-title":"J Thromb Haemost"},{"key":"2041_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ahj.2008.06.004","volume":"156","author":"Angiolillo","year":"2008","unstructured":"Angiolillo DJ, Capranzano P (2008) Pharmacology of emerging novel platelet inhibitors. Am Heart J 156:10\u201315","journal-title":"Am Heart J"},{"key":"2041_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","volume":"307","author":"Angiolillo","year":"2012","unstructured":"Angiolillo DJ, Firstenberg MS, Price MJ et al (2012) Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 307:265\u2013274","journal-title":"JAMA"},{"key":"2041_CR5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcin.2009.03.014","volume":"2","author":"Anwaruddin","year":"2009","unstructured":"Anwaruddin S, Askari AT, Saudye H et al (2009) Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2:542\u2013549","journal-title":"JACC Cardiovasc Interv"},{"key":"2041_CR6","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2008.08.031","volume":"52","author":"Berger","year":"2008","unstructured":"Berger JS, Frye CB, Harshaw Q et al (2008) Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. Am J Coll Cardiol 52:1693\u20131701","journal-title":"Am J Coll Cardiol"},{"key":"2041_CR7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jcin.2010.03.021","volume":"3","author":"Berger","year":"2010","unstructured":"Berger PB, Kleiman NS, Pencina MJ et al (2010) Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 3:920\u2013927","journal-title":"JACC Cardiovasc Interv"},{"key":"2041_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","volume":"49","author":"Bliden","year":"2007","unstructured":"Bliden KP, DiChiara J, Tantry US et al (2007) Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 49:657\u2013666","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MBC.0b013e3283424911","volume":"22","author":"Bochsen","year":"2011","unstructured":"Bochsen L, Johansson PI, Kristensen AT et al (2011) The influence of platelets, plasma and red blood cells on functional haemostatic assays. Blood Coagul Fibrinolysis 22:167\u2013175","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2041_CR10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1538-7836.2007.02609.x","volume":"5","author":"Bonello","year":"2007","unstructured":"Bonello L, Paganelli F, Arpin-Bornet M et al (2007) Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 5:1630\u20131636","journal-title":"J Thromb Haemost"},{"key":"2041_CR11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","volume":"56","author":"Bonello","year":"2010","unstructured":"Bonello L, Tantry US, Marcucci R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919\u2013933","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1538-7836.2009.03733.x","volume":"8","author":"Bouman","year":"2010","unstructured":"Bouman HJ, Parlak E, Werkum JW van et al (2010) Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel. J Thromb Haemost 8:482\u2013488","journal-title":"J Thromb Haemost"},{"key":"2041_CR13","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","volume":"58","author":"Brar","year":"2011","unstructured":"Brar SS, Berg J ten, Marcucci R et al (2011) Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol 58:1945\u20131954","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","volume":"303","author":"Breet","year":"2010","unstructured":"Breet NJ, Werkum JW van, Bouman HJ et al (2010) Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 303:754\u2013562","journal-title":"JAMA"},{"key":"2041_CR15","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","volume":"49","author":"Buonamici","year":"2007","unstructured":"Buonamici P, Marcucci R, Migliorini A et al (2007) Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49:2312\u20132317","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/SLA.0b013e3181e40dde","volume":"252","author":"Burdess","year":"2011","unstructured":"Burdess A, Nimmo AF, Garden OJ et al (2011) Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg 252:37\u201342","journal-title":"Ann Surg"},{"key":"2041_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2004.02.019","volume":"128","author":"Chen","year":"2004","unstructured":"Chen L, Bracey AW, Radovancevic R et al (2004) Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128:425\u2013431","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2041_CR18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/ALN.0b013e31818db18b","volume":"109","author":"Crescenzi","year":"2008","unstructured":"Crescenzi G, Landoni G, Biondi-Zoccai G et al (2008) Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. Anesthesiology 109:1063\u20131076","journal-title":"Anesthesiology"},{"key":"2041_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703","volume":"3","author":"Cruden","year":"2010","unstructured":"Cruden NL, Harding SA, Flapan AD et al (2010) Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 3:236\u2013242","journal-title":"Circ Cardiovasc Interv"},{"key":"2041_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ahj.2010.10.037","volume":"161","author":"Cruden","year":"2011","unstructured":"Cruden NL, Morch K, Wong DR et al (2011) Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting. Am Heart J 161:404\u2013410","journal-title":"Am Heart J"},{"key":"2041_CR21","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","volume":"371","author":"Devereaux","year":"2008","unstructured":"Devereaux PJ, Yang H, Yusuf S et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839\u20131847","journal-title":"Lancet"},{"key":"2041_CR22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1538-7836.2009.03331.x","volume":"7","author":"Fenger-Eriksen","year":"2009","unstructured":"Fenger-Eriksen C, Jensen TM, Kristensen BS et al (2009) Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 7:795\u2013802","journal-title":"J Thromb Haemost"},{"key":"2041_CR23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","volume":"91","author":"Ferraris","year":"2011","unstructured":"Ferraris VA, Brown JR, Despotis GJ et al (2011) 2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91:944\u2013982","journal-title":"Ann Thorac Surg"},{"key":"2041_CR24","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.athoracsur.2011.01.025","volume":"91","author":"Ferraris","year":"2011","unstructured":"Ferraris VA, Davenport DL, Saha SP et al (2011) Intraoperative transfusion of small amounts of blood heralds worse postoperative outcome in patients having noncardiac thoracic operations. Ann Thorac Surg 91:1674\u20131680","journal-title":"Ann Thorac Surg"},{"key":"2041_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1160\/TH11-02-0077","volume":"106","author":"Freynhofer","year":"2011","unstructured":"Freynhofer MK, Brozovic I, Bruno V et al (2011) Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events. Thromb Haemost 106:230\u2013239","journal-title":"Thromb Haemost"},{"key":"2041_CR26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/ALN.0b013e3182054d06","volume":"114","author":"Glance","year":"2011","unstructured":"Glance LG, Dick AW, Mukamel DB et al (2011) Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 114:283\u2013292","journal-title":"Anesthesiology"},{"key":"2041_CR27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","volume":"27","author":"Gogarten","year":"2010","unstructured":"Gogarten W, Vandermeulen E, Van Aken H et al (2010) Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 27:999\u20131015","journal-title":"Eur J Anaesthesiol"},{"key":"2041_CR28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/ALN.0b013e31823497dd","volume":"115","author":"G\u00f6rlinger","year":"2011","unstructured":"G\u00f6rlinger K, Dirkmann D, Hanke AA et al (2011) First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 115:1179\u20131191","journal-title":"Anesthesiology"},{"key":"2041_CR29","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","volume":"50","author":"Gurbel","year":"2007","unstructured":"Gurbel PA, Becker RC, Mann KG et al (2007) Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 50:1822\u20131834","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR30","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","volume":"120","author":"Gurbel","year":"2009","unstructured":"Gurbel PA, Bliden KP, Butler K et al (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study. Circulation 120:2577\u20132585","journal-title":"Circulation"},{"key":"2041_CR31","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","volume":"46","author":"Gurbel","year":"2005","unstructured":"Gurbel PA, Bliden KP, Guyer K et al (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study. J Am Coll Cardiol 46:1820\u20131826","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR32","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","volume":"107","author":"Gurbel","year":"2003","unstructured":"Gurbel PA, Bliden KP, Hiatt BL et al (2003) Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107:2908\u20132913","journal-title":"Circulation"},{"key":"2041_CR33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.2011.332","volume":"305","author":"Gurbel","year":"2011","unstructured":"Gurbel PA, Tantry US (2011) An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial. JAMA 305:1136\u20131137","journal-title":"JAMA"},{"key":"2041_CR34","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999\u20133054","journal-title":"Eur Heart J"},{"key":"2041_CR35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/2047-783X-15-2-59","volume":"15","author":"Hanke","year":"2010","unstructured":"Hanke AA, Roberg K, Monaca E et al (2010) Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate). Eur J Med Res 15:214\u2013219","journal-title":"Eur J Med Res"},{"key":"2041_CR36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","volume":"57","author":"Held","year":"2011","unstructured":"Held C, Asenblad N, Bassand JP et al (2011) Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 57:672\u2013684","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.athoracsur.2009.10.051","volume":"89","author":"Herman","year":"2010","unstructured":"Herman CR, Buth KJ, Kent BA et al (2010) Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 89:397\u2013402","journal-title":"Ann Thorac Surg"},{"key":"2041_CR38","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/CIR.0b013e31823b5fee","volume":"124","author":"Hillis","year":"2011","unstructured":"Hillis LD, Smith PK, Anderson JL et al (2011) 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery. Circulation 124:2610\u20132642","journal-title":"Circulation"},{"key":"2041_CR39","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","volume":"48","author":"Hochholzer","year":"2006","unstructured":"Hochholzer W, Trenk D, Bestehorn HP et al (2006) Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48:1742\u20131750","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR40","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","volume":"306","author":"Holmes","year":"2011","unstructured":"Holmes MV, Perel P, Shah T et al (2011) CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA 306:2704\u20132714","journal-title":"JAMA"},{"key":"2041_CR41","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","volume":"27","author":"Husted","year":"2006","unstructured":"Husted S, Emanuelsson H, Heptinstall S et al (2006) Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J 27:1038\u20131047","journal-title":"Eur Heart J"},{"key":"2041_CR42","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126\u20132130","journal-title":"JAMA"},{"key":"2041_CR43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.fjc.0000210069.47205.c0","volume":"47","author":"Jakubowski","year":"2006","unstructured":"Jakubowski JA, Payne CD, Brandt JT et al (2006) The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjects. J Cardiovasc Pharmacol 47:377\u2013384","journal-title":"J Cardiovasc Pharmacol"},{"key":"2041_CR44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00101-009-1628-7","volume":"58","author":"Jambor","year":"2009","unstructured":"Jambor C, Spannagl M, Zwissler B (2009) Perioperative management of patients with coronary stents in non-cardiac surgery. Anaesthesist 58:971\u2013985","journal-title":"Anaesthesist"},{"key":"2041_CR45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1538-7836.2011.04604.x","volume":"10","author":"Jeong","year":"2012","unstructured":"Jeong YH, Bliden KP, Tantry US et al (2012) High on-treatment platelet reactivity assessed by various platelet function tests: is the consensus-defined cut-off of VASP-P platelet reactivity index too low? J Thromb Haemost 10:487\u2013489","journal-title":"J Thromb Haemost"},{"key":"2041_CR46","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0735-1097(00)00521-0","volume":"35","author":"Kaluza","year":"2000","unstructured":"Kaluza GL, Joseph J, Lee JR et al (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288\u20131294","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR47","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2010.03.108","volume":"56","author":"Kwak","year":"2010","unstructured":"Kwak YL, Kim JC, Choi YS et al (2010) Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol 56:1994\u20132002","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1213\/ane.0b013e3181966675","volume":"108","author":"Lang","year":"2009","unstructured":"Lang T, Johanning K, Metzler H et al (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 108:751\u2013758","journal-title":"Anesth Analg"},{"key":"2041_CR49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000047060.60595.CC","volume":"107","author":"Lau","year":"2003","unstructured":"Lau WC, Waskell LA, Watkins PB et al (2003) Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 107:32\u201337","journal-title":"Circulation"},{"key":"2041_CR50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1538-7836.2009.03287.x","volume":"7","author":"Lauritzen","year":"2009","unstructured":"Lauritzen B, Tranholm M, Ezban M (2009) rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. J Thromb Haemost 7:651\u2013657","journal-title":"J Thromb Haemost"},{"key":"2041_CR51","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/CIR.0b013e31823a5596","volume":"124","author":"Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC et al (2011) 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. Circulation 124:2574\u20132609","journal-title":"Circulation"},{"key":"2041_CR52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/ALN.0b013e31820ad503","volume":"114","author":"Levy","year":"2011","unstructured":"Levy M, Heels-Ansdell D, Hiralal R et al (2011) Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 114:796\u2013806","journal-title":"Anesthesiology"},{"key":"2041_CR53","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.athoracsur.2010.04.041","volume":"90","author":"Mahla","year":"2010","unstructured":"Mahla E, Metzler H, Tantry US et al (2010) Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. Ann Thorac Surg 90:1040\u20131051","journal-title":"Ann Thorac Surg"},{"key":"2041_CR54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","volume":"5","author":"Mahla","year":"2012","unstructured":"Mahla E, Suarez TA, Bliden KP et al (2012) Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the Timing Based on Platelet Function Strategy to Reduce Clopidogrel-Associated Bleeding Related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 5:261\u2013269","journal-title":"Circ Cardiovasc Interv"},{"key":"2041_CR55","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","volume":"347","author":"Mangano","year":"2002","unstructured":"Mangano DT (2002) Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309\u20131317","journal-title":"N Engl J Med"},{"key":"2041_CR56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH10-01-0007","volume":"104","author":"Marcucci","year":"2010","unstructured":"Marcucci R, Gori AM, Paniccia R et al (2010) High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting. Thromb Haemost 104:279\u2013286","journal-title":"Thromb Haemost"},{"key":"2041_CR57","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","volume":"109","author":"Matetzky","year":"2004","unstructured":"Matetzky S, Shenkman B, Guetta V et al (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109:3171\u20133175","journal-title":"Circulation"},{"key":"2041_CR58","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(10)61273-1","volume":"376","author":"Mega","year":"2010","unstructured":"Mega JL, Close SL, Wiviott SD et al (2010) Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet 376:1312\u20131319","journal-title":"Lancet"},{"key":"2041_CR59","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2011.1703","volume":"306","author":"Mega","year":"2011","unstructured":"Mega JL, Hochholzer W, Frelinger AL III et al (2011) Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA 306:2221\u20132228","journal-title":"JAMA"},{"key":"2041_CR60","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","volume":"304","author":"Mega","year":"2010","unstructured":"Mega JL, Simon T, Collet JP et al (2010) Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 304:1821\u20131830","journal-title":"JAMA"},{"key":"2041_CR61","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736\u20132747","journal-title":"Circulation"},{"key":"2041_CR62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00101-007-1171-3","volume":"56","author":"Metzler","year":"2007","unstructured":"Metzler H, Huber K, Kozek-Langenecker S et al (2007) Coronary stents, dual antiplatelet therapy and peri-operative problems. Anaesthesist 56:401\u2013410 (quiz 411\u2013402)","journal-title":"Anaesthesist"},{"key":"2041_CR63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4244\/EIJV6I2A31","volume":"6","author":"Moschovitis","year":"2010","unstructured":"Moschovitis A, Cook S, Meier B (2010) Percutaneous coronary interventions in Europe in 2006. EuroIntervention 6:189\u2013194","journal-title":"EuroIntervention"},{"key":"2041_CR64","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1093\/eurheartj\/ehr151","volume":"23","author":"Nijjer","year":"2011","unstructured":"Nijjer SS, Watson G, Athanasiou T, Malik IS (2011) Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. Eur Heart J 23:2970\u20132988","journal-title":"Eur Heart J"},{"key":"2041_CR65","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00000542-200105000-00014","volume":"94","author":"Nuttall","year":"2001","unstructured":"Nuttall GA, Oliver WC, Santrach PJ et al (2001) Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94:773\u2013781","journal-title":"Anesthesiology"},{"key":"2041_CR66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","volume":"295","author":"O","year":"2006","unstructured":"O\u2019Connell KA, Wood JJ, Wise RP et al (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295:293\u2013298","journal-title":"JAMA"},{"key":"2041_CR67","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","volume":"374","author":"O","year":"2009","unstructured":"O\u2019Donoghue ML, Braunwald E, Antman EM et al (2009) Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 374:989\u2013997","journal-title":"Lancet"},{"key":"2041_CR68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/eurheartj\/ehm049","volume":"28","author":"Ouattara","year":"2007","unstructured":"Ouattara A, Bouzguenda H, Le Manach Y et al (2007) Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin. Eur Heart J 28:1025\u20131032","journal-title":"Eur Heart J"},{"key":"2041_CR69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1378\/chest.08-0672","volume":"133","author":"Patrono","year":"2008","unstructured":"Patrono C, Baigent C, Hirsh J et al (2008) Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:199\u2013233","journal-title":"Chest"},{"key":"2041_CR70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","volume":"305","author":"Price","year":"2011","unstructured":"Price MJ, Berger PB, Teirstein PS et al (2011) Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305:1097\u20131105","journal-title":"JAMA"},{"key":"2041_CR71","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","volume":"29","author":"Price","year":"2008","unstructured":"Price MJ, Endemann S, Gollapudi RR et al (2008) Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29:992\u20131000","journal-title":"Eur Heart J"},{"key":"2041_CR72","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/ALN.0b013e318186de1c","volume":"109","author":"Rabbitts","year":"2008","unstructured":"Rabbitts JA, Nuttall GA, Brown MJ et al (2008) Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 109:596\u2013604","journal-title":"Anesthesiology"},{"key":"2041_CR73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","volume":"91","author":"Ranucci","year":"2011","unstructured":"Ranucci M, Baryshnikova E, Soro G et al (2011) Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 91:123\u2013129","journal-title":"Ann Thorac Surg"},{"key":"2041_CR74","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2011.04456.x","volume":"9","author":"Savonitto","year":"2011","unstructured":"Savonitto S, Caracciolo M, Cattaneo M et al (2011) Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost 9:2133\u20132142","journal-title":"J Thromb Haemost"},{"key":"2041_CR75","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2007.01.097","volume":"50","author":"Saw","year":"2007","unstructured":"Saw J, Brennan DM, Steinhubl SR et al (2007) Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol 50:291\u2013295","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR76","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1213\/00000539-199902000-00016","volume":"88","author":"Shore-Lesserson","year":"1999","unstructured":"Shore-Lesserson L, Manspeizer HE, DePerio M et al (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88:312\u2013319","journal-title":"Anesth Analg"},{"key":"2041_CR77","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","volume":"53","author":"Sibbing","year":"2009","unstructured":"Sibbing D, Braun S, Morath T et al (2009) Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 53:849\u2013856","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1160\/TH11-01-0040","volume":"106","author":"Sibbing","year":"2011","unstructured":"Sibbing D, Byrne RA, Bernlochner I et al (2011) High platelet reactivity and clinical outcome \u2013 Fact and fiction. Thromb Haemost 106:191\u2013202","journal-title":"Thromb Haemost"},{"key":"2041_CR79","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1538-7836.2009.03709.x","volume":"8","author":"Sibbing","year":"2010","unstructured":"Sibbing D, Schulz S, Braun S et al (2010) Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 8:250\u2013256","journal-title":"J Thromb Haemost"},{"key":"2041_CR80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1538-7836.2009.03699.x","volume":"8","author":"Siller-Matula","year":"2009","unstructured":"Siller-Matula JM, Christ G, Lang IM et al (2009) Multiple electrode aggregometry better predicts stent thrombosis than the VASP assay. J Thromb Haemost 8:351\u2013359","journal-title":"J Thromb Haemost"},{"key":"2041_CR81","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2008.07.055","volume":"52","author":"Siller-Matula","year":"2008","unstructured":"Siller-Matula JM, Lang I, Christ G et al (2008) Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 52:1557\u20131563","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ahj.2008.09.017","volume":"157","author":"Siller-Matula","year":"2009","unstructured":"Siller-Matula JM, Spiel AO, Lang IM et al (2009) Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J 157:148 e141\u2013145","journal-title":"Am Heart J"},{"key":"2041_CR83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","volume":"154","author":"Snoep","year":"2007","unstructured":"Snoep JD, Hovens MM, Eikenboom JC et al (2007) Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 154:221\u2013231","journal-title":"Am Heart J"},{"key":"2041_CR84","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","volume":"113","author":"Spertus","year":"2006","unstructured":"Spertus JA, Kettelkamp R, Vance C et al (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113:2803\u20132809","journal-title":"Circulation"},{"key":"2041_CR85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2010.01.062","volume":"56","author":"Storey","year":"2010","unstructured":"Storey RF, Bliden KP, Patil SB et al (2010) Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET\/OFFSET study. J Am Coll Cardiol 56:185\u2013193","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR86","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","volume":"50","author":"Storey","year":"2007","unstructured":"Storey RF, Husted S, Harrington RA et al (2007) Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol 50:1852\u20131856","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR87","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/13543784.15.12.1627","volume":"15","author":"Tantry","year":"2006","unstructured":"Tantry US, Bliden KP, Gurbel PA (2006) Prasugrel. Expert Opin Investig Drugs 15:1627\u20131633","journal-title":"Expert Opin Investig Drugs"},{"key":"2041_CR88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1160\/THS11-01-0025","volume":"105","author":"Tentzeris","year":"2011","unstructured":"Tentzeris I, Siller-Matula J, Farhan S et al (2011) Platelet function variability and non-genetic causes. Thromb Haemost 105(Suppl 1):60\u201366","journal-title":"Thromb Haemost"},{"key":"2041_CR89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCINTERVENTIONS.108.830158","volume":"2","author":"To","year":"2009","unstructured":"To AC, Armstrong G, Zeng I et al (2009) Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv 2:213\u2013221","journal-title":"Circ Cardiovasc Interv"},{"key":"2041_CR90","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","volume":"51","author":"Trenk","year":"2008","unstructured":"Trenk D, Hochholzer W, Fromm MF et al (2008) Cytochrome P450 2C19 681G > A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 51:1925\u20131934","journal-title":"J Am Coll Cardiol"},{"key":"2041_CR91","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.amjcard.2009.06.038","volume":"104","author":"Kuijk","year":"2009","unstructured":"Kuijk JP van, Flu WJ, Schouten O et al (2009) Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 104:1229\u20131234","journal-title":"Am J Cardiol"},{"key":"2041_CR92","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2007.02481.x","volume":"5","author":"Velik-Salchner","year":"2007","unstructured":"Velik-Salchner C, Haas T, Innerhofer P et al (2007) The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 5:1019\u20131025","journal-title":"J Thromb Haemost"},{"key":"2041_CR93","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/bja\/ael083","volume":"96","author":"Vicenzi","year":"2006","unstructured":"Vicenzi MN, Meislitzer T, Heitzinger B et al (2006) Coronary artery stenting and non-cardiac surgery\u2013a prospective outcome study. Br J Anaesth 96:686\u2013693","journal-title":"Br J Anaesth"},{"key":"2041_CR94","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1160\/TH11-01-0046","volume":"106","author":"Voisin","year":"2011","unstructured":"Voisin S, Bongard V, Tidjane MA et al (2011) Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels. Thromb Haemost 106:227\u2013229","journal-title":"Thromb Haemost"},{"key":"2041_CR95","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","volume":"30","author":"Wallentin","year":"2009","unstructured":"Wallentin L (2009) P2Y (12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 30:1964\u20131977","journal-title":"Eur Heart J"},{"key":"2041_CR96","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"2041_CR97","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(10)61274-3","volume":"376","author":"Wallentin","year":"2010","unstructured":"Wallentin L, James S, Storey RF et al (2010) Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet 376:1320\u20131328","journal-title":"Lancet"},{"key":"2041_CR98","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1213\/ANE.0b013e3181e456c1","volume":"111","author":"Wasowicz","year":"2010","unstructured":"Wasowicz M, McCluskey SA, Wijeysundera DN et al (2010) The incremental value of thrombelastography for prediction of excessive blood loss after cardiac surgery: an observational study. Anesth Analg 111:331\u2013338","journal-title":"Anesth Analg"},{"key":"2041_CR99","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"Wijns","year":"2010","unstructured":"Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501\u20132555","journal-title":"Eur Heart J"},{"key":"2041_CR100","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"2041_CR101","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIR.0b013e31820f2f3e","volume":"123","author":"Wright","year":"2011","unstructured":"Wright RS, Anderson JL, Adams CD et al (2011) 2011 ACCF\/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina\/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 123:2022\u20132060","journal-title":"Circulation"},{"key":"2041_CR102","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/CIR.0b013e3181ee08ed","volume":"122","author":"Writing","year":"2010","unstructured":"Writing Committee Members, Holmes DR Jr, Dehmer GJ et al (2010) ACCF\/AHA clopidogrel clinical alert: approaches to the FDA \u201eboxed warning\u201c: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation 122:537\u2013557","journal-title":"Circulation"},{"key":"2041_CR103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1160\/THS10-11-0747","volume":"105","author":"Yukhanyan","year":"2011","unstructured":"Yukhanyan L, Freynhofer MK, Siller-Matula J et al (2011) Genetic variability in response to clopidogrel therapy and its clinical implications. Thromb Haemost 105(Suppl 1):55\u201359","journal-title":"Thromb Haemost"},{"key":"2041_CR104","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR et al (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494\u2013502","journal-title":"N Engl J Med"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-012-2041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-012-2041-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-012-2041-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:46:59Z","timestamp":1687513619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-012-2041-1"}},"subtitle":["M\u00f6gliche Auswirkungen auf die operative Medizin?","Possible impacts on operative medicine?"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2041"],"URL":"https:\/\/doi.org\/10.1007\/s00101-012-2041-1","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}